Abstract
Potassium channels participate in many biological functions, from ion homeostasis to generation and modulation of the electrical membrane potential. They are involved in a large variety of diseases. In the human genome, 15 genes code for K+ channels with two pore domains (K2P). These channels form dimers of pore-forming subunits that produce background conductances finely regulated by a range of natural and chemical effectors, including signalling lipids, temperature, pressure, pH, antidepressants and volatile anaesthetics. Since the cloning of TWIK1, the prototypical member of this family, a lot of work has been carried out on their structure and biology. These studies are still in progress, but data gathered so far show that K2P channels are central players in many processes, including ion homeostasis, hormone secretion, cell development and excitability. A growing number of studies underline their implication in physiopathological mechanisms, such as vascular and pulmonary hypertension, cardiac arrhythmias, nociception, neuroprotection and depression. This review gives a synthetic view of the most noticeable features of these channels.
Introduction
Potassium channels are important for K+ transport and cell volume regulation. By modulating the electrical membrane potential, they are also necessary for functions as diverse as neurotransmission, neuronal coding of information, heart beating, muscle contraction and hormone secretion. With more than 78 genes encoding pore-forming subunits in the human genome, K+ channels form the largest ion channel family. This family comprises three different structural subclasses related to voltage-gated K+ (Kv) channels, inward rectifiers (Kir) and two-pore domain K+ (K2P) channels (Goldstein et al. 2005; Gutman et al. 2005; Kubo et al. 2005; Wei et al. 2005; González et al. 2012). While the prototypical members of the Kv and Kir subclasses were cloned on purpose using genetics and/or expression cloning, K2P channels were identified by DNA database mining without clues about the electrophysiological and functional properties of their native correlates (Lesage et al. 1996). In heterologous systems, they were found to produce currents similar to native currents previously identified in cardiac and neuronal cells, including background K+ currents, arachidonic acid-activated K+ current and mechano-gated K+ currents (for examples, see Franks & Lieb, 1988; Premkumar et al. 1990; Sackin, 1995; Kim et al. 1995). Fifteen genes (denoted KCNKx) encode K2P channel pore-forming subunits. Alternative splicing and translation initiation, heteromerization and post-translational modifications further increase this diversity. These channels are regulated by a wide range of physical and chemical stimuli and are the targets of drugs such as anaesthetics, neuroprotective and antidepressive agents. The K2P channels are involved in the development and excitability of many cell types. The characterization of their physiological and pathological functions is still ongoing, mainly using animal models. The scope of this review is to provide a synthetic overview of the most salient features of these channels. For in-depth information, the reader is referred to several exhaustive reviews (Enyedi & Czirják, 2010; Mathie et al. 2010; Noël et al. 2011; Lesage & Barhanin, 2011).
Structural features of the K2P channels
Potassium channels contain a short signature sequence called the pore (P) domain. The assembly of four P domains forms the selectivity filter of an active channel (Doyle et al. 1998). All the subunits directly related to Kv and Kir channels contain a single P domain and assemble as tetramers. TWIK1, the prototypical member of the K2P channel class, was found by identifying a non-conventional P domain in an expressed sequence tag from human kidney (Lesage et al. 1996a). Cloning and sequencing of the corresponding full-length cDNA revealed the presence of two P domains (P1 and P2), while biochemical experiments showed that TWIK1 was able to form dimers containing four P domains, each P domain being flanked by two membrane-spanning helices (M1, M2, M3 and M4, respectively; Fig. 1A). The N- and C-termini of TWIK1 are cytoplasmic. Another unique feature is the presence of an extended extracellular loop between domains M1 and P1. This M1P1 loop is a coiled–coiled domain that interacts with the same structure of the other subunit of the dimer (Lesage et al. 1996b). It contains a cysteine residue (Cys69) involved in the formation of a covalent bridge between two subunits (Lesage et al. 1996b). Purification and crystallization of TWIK1 (Miller & Long, 2012) and of the related TRAAK channel (Brohawn et al. 2012) have confirmed this organization, showing that the P domains are organized with a pseudo-fourfold symmetry (Fig. 1B). Both structures also showed that the M1P1 loop is highly structured into a helical cap that provides an ion pathway, in which K+ ions flow through side-portals. Disulfide-bridged cysteines are at the top of the cap and stabilize the structure. The crystals also revealed the existence of fenestrations that expose the inner pore of the channel to the lipid bilayer.
Figure 1.

Structural organization of K2P channels
A, schematic representation of K2P subunit organization, with the two pore domains (in pink), the four transmembrane domains (in blue) and the extracellular cap (in green). B, three-dimensional reconstruction of TWIK1 deduced from the crystal structure (Miller & Long, 2012; Protein Data Bank identity code 3UKM). The different domains are represented with the same colour code as in A. C, dendrogram of the 15 K2P subunits with their conventional and systematic names.
By sequence homology, 14 subunits related to TWIK1 were cloned that display the same overall organization. Based on sequence conservation and functional properties, these subunits were classified into the following six groups: TWIK for Two P-domain in a weakly inward rectifying K+ channel; TREK (TWIK-related K+ channel); TASK (TWIK-related acid-sensitive K+ channel); TALK (TWIK-related alkaline-sensitive K+ channel); THIK (Tandem pore domain halotane-inhibited K+ channel); and TRESK (TWIK-related spinal cord K+ channel; Fig. 1C). The only noticeable variations in the structural organization are the absence of a disulfide bond in the caps of TASK1 and TASK3 dimers and the presence of a long intracellular M2M3 loop in TRESK (Enyedi et al. 2012). While regulation by the cellular machinery involves the C-terminus of many K2P channels, known regulations of TRESK take place in this M2M3 loop. Usually, a KCNK gene produces a unique K2P subunit. However, the TREK/TRAAK subclass exhibits additional subunit diversity. Alternative transcription initiation leads to the production of TREK1 and TREK2 variants with a shortened cytoplasmic N-terminus, associated with a change of ionic selectivity for TREK1 (Thomas et al. 2008) and a change of unitary conductance for TREK2 (Simkin et al. 2008). In addition, alternative exon splicing produces variants of TREK1, TREK2 and TRAAK with variable levels of activity (Fink et al. 1996; Lesage et al. 2000a, b; Gu et al. 2002; Ozaita & Vega-Saenz de Miera, 2002; Veale et al. 2010; Rinné et al. 2014). Tissue-specific expression of some variants and the dominant-negative effect of one of them suggest that alternative splicing may be involved in the functional regulation of TREK/TRAAK channels.
Electrophysiological properties of the K2P channels
Unlike Kv channels, K2P channels have no voltage sensor and are not gated by the membrane potential (Fink et al. 1996; Lesage et al. 1996a; Duprat et al. 1997). Many of them produce almost instantaneous and non-inactivating currents over the whole range of the membrane potential. These properties mark them as background or leak K+ channels, predicted to follow the Goldman–Hodgkin–Katz current equation for a K+-selective leak current. If TASK1 currents follow this equation perfectly (Duprat et al. 1997), others exhibit some variations, such as a slight outward (TREK1; Bockenhauer et al. 2001; Fink et al. 1996) or inward rectification (TWIK1 and TWIK2; Lesage et al. 1996a; Patel et al. 2000). Other unusual features are observed, such as a slow inactivating component that represents about 50% of the TWIK2 current (Patel et al. 2000), different subconductance states for TREK1 and TREK2 (Fink et al. 1996; Patel et al. 1998; Lesage et al. 2000b; Kang et al. 2007; Simkin et al. 2008) and an asymmetrical gating behaviour for TRESK (Czirják et al. 2004). Regardless of these differences, K2P channels are all insensitive or very weakly sensitive to the classical K+ channel blockers, such as tetraethyl ammonium, Ba2+, Cs+ and 4-aminopyridine. This lack of specific pharmacology as well as their time and voltage independences explain why these currents have been overlooked despite their presence in many tissues and cells. However, even if these channels behave as leaks, they are finely regulated by many different stimuli (Table1), and these regulations have proved to be very useful to correlate cloned and native channels.
Table 1.
Natural and chemical effectors of K2P channels, remarkable features and interacting partners
![]() |
Abbreviations: PUFA, polyunsaturated fatty acid; LP, lysophopholipid; ER, endoplasmic reticulum; COP-I, coat protein 1; AKAP-150, A-kinase anchoring protein 150; Mtap2, microtubule-associated protein 2. Superscripts are as follows: 1, Lesage et al. (1996); 2, Feliciangeli et al. (2010); 3, Rajan et al. (2005); 4, Chatelain et al. (2012); 5, Hwang et al. (2014); 6, Plant et al. (2012); 7, Decressac et al. (2004); 8, Chavez et al. (1999); 9, Pountney et al. (1999); 10, Patel et al. (2000); 11, Salinas et al. (1999); 12, Fink et al. (1996); 13, Koh et al. (2001); 14, Gruss et al. (2004); 15, Woo et al. (2012); 16, Bagriantsev et al. (2013); 17, Rodrigues et al. (2014); 18, Maingret et al. (1999); 19, Lesage et al. (2000); 20, Patel et al. (1999); 21, Maingret et al. (1999); 22, Patel et al. (1998); 23, Fink et al. (1998); 24, Bang et al. (2000); 25, Maingret et al. (2000b); 26, Maingret et al. (2000a); 27, Kang et al. (2005); 28, Duprat et al. (2000); 29, Cohen et al. (2008); 30, Kennard et al. (2005); 31, Mazella et al. (2010); 32, Li et al. (2006); 33, Kang et al. (2007); 34, Thomas et al. (2008); 35, Simkin et al. (2008); 36, Kim et al. (2010); 37, Azzalin et al. (2006); 38, Sandoz et al. (2006); 39, Sandoz et al. (2008); 40, Comoglio et al. (2014); 41, Sandoz et al. (2009); 42, Kang et al. (2012); 43, Kim et al. (2001a); 44, Czirják & Enyedi (2002); 45, Duprat et al. (1997); 46, Talley & Bayliss (2002); 47, Kemp et al. (2004); 48, Kim et al. (2000); 49, Rajan et al. (2000); 50, Chen et al. (2006); 51, Bautista et al. (2008); 52, Lauritzen et al. (2003); 53, Ma et al. (2012); 54, Lopes et al. (2000); 55, Meadows & Randall (2001); 56, Girard et al. (2002); 57, Renigunta et al. (2014); 58, O’Kelly et al. (2002); 59, Zuzarte et al. (2009); 60, Kim & Gnatenco (2001); 61, Ashmole et al. (2001); 62, Reyes et al. (1998); 63, Niemeyer et al. (2010); 64, Kang & Kim (2004); 65, Añazco et al. (2013); 66, Girard et al. (2001); 67, Duprat et al. (2005); 68, Rajan et al. (2001); 69, Campanucci et al. (2005); 70, Chatelain et al. (2013); 71, Blin et al. (2014); 72, Renigunta et al. (2014); 73, Sano et al. (2003); 74, Liu et al. (2004); 75, Czirják et al. (2004); 76, Rahm et al. (2012); 77, Czirják et al. (2008); 78, Enyedi et al. (2014).
Recent observations suggest that the gating mechanism in K2P channels may be different from those of other K+ channels. In Kir and Kv channels, modulation of the activity occurs via the opening/closure of two distinct gates. The upper (or outer) gate takes place at the selectivity filter, whereas the lower (or inner) gate comprises the lower part of the inner membrane-spanning helices. Functional studies and crystal structure suggest that the access to the inner pore cavity is not modified by different stimuli that regulate K2P channel activity, leading to a model in which the primary activation mechanisms reside close to or within the selectivity filter and do not involve gating at the lower cytoplasmic bundle crossing (Bagriantsev et al. 2011, 2012; Piechotta et al. 2011; Brohawn et al. 2012; Miller & Long, 2012).
Regulation of the K2P channels by pH
Except for THIK1/2 and TRESK, K2P channels are sensitive to pH. The TASK and TALK channels are inhibited by acidification of the extracellular medium. The pKa value of this inhibition makes some channels active at neutral pH and inhibited by acid (pKa of 7.3 for TASK1 and 6.7 for TASK3; Duprat et al. 1997; Kim et al. 2000; Rajan et al. 2000) and others active at alkaline pH and less active (TASK2), largely inhibited (TALK1) or totally inhibited (TALK2) at neutral pH (Reyes et al. 1998; Kang & Kim, 2004). The pH sensor is constituted primarily of a histidine residue in the P1 domain of TASK1 (Morton et al. 2003) and TASK3 (Kim et al. 2000; Rajan et al. 2000) and of a basic residue in the P2M4 loop of the TALKs (Niemeyer et al. 2006, 2007). In the TREK/TRAAK subfamily, the effect of the pH is more contrasted. The TREK1 and TREK2 channels are activated by internal acidification, whereas TRAAK is activated by internal alkalinization. External acidification inhibits TREK1 and TRAAK but activates TREK2 (Duprat et al. 1997; Maingret et al. 1999b; Kim et al. 2001a, b Sandoz et al. 2009). The sensor for activation of TREK1 and TREK2, but not TRAAK, by internal pH is located in their C-termini (Maingret et al. 1999b; Kim et al. 2001b). The sensitivity to external pH requires a histidine residue in the M1P1 loop (Sandoz et al. 2009). Residues in the P2M4 loop, negatively charged in TREK1 and positively charged in TREK2, are responsible for the opposite effect of acidification on these channels, suggesting electrostatic attraction/repulsion, with the protonated side-chain of the histidine sensor leading to the opening or the closure of the pore. TWIK1 also displays a marked sensitivity to extracellular acidification, but with a very different effect. The channel reversibly shifts from a strict selectivity to K+ at neutral pH to a state permeable to Na+ at acidic pH, demonstrating that TWIK1 possesses a dynamic ion selectivity (Chatelain et al. 2012). A low K+ concentration has the same effect (Ma et al. 2011). This loss of K+ selectivity would cause paradoxical depolarization of human cardiac cells in pathological hypokalaemic conditions (Chen et al. 2014). Based on these findings, it was also reported that acidification affects the ion selectivity of TASK1 and TASK3 (Ma et al. 2012). These data show that external parameters can affect ion selectivity of K2P channels. This finding expands the range of potential roles for K2P channels that may also behave as excitatory channels when they are permeable to Na+.
Unique regulation of TWIK1
Dynamic ion selectivity of TWIK1 has been reported only very recently, although the channel was identified almost two decades ago (Lesage et al. 1996a). This lag was due to the difficulty in studying TWIK1 currents. Indeed, no native currents corresponding to TWIK1 have been characterized so far, and its weak activity was recorded only in a few heterologous expression systems. The identification of highly active K2P channels soon after the discovery of TWIK1 overshadowed its study for a time. Two models were proposed to explain the lack of TWIK1 expression. In the first model, TWIK1 is present at the plasma membrane but silenced by the binding of a small ubiquitin-like modifier (SUMO) polypeptide to a non-conventional SUMO binding site (Rajan et al. 2005). When this site is inactivated by mutagenesis, the corresponding channel produces measurable currents. Following this line, the authors later reported that TWIK1 heteromerizes with TASK1/3 subunits and brings sumoylation sensitivity to the TWIK1/TASK heteromeric complexes (Plant et al. 2012). In the second model, low activity of TWIK1 is explained by its intracellular localization. The channel is rapidly and constitutively endocytosed from the plasma membrane and accumulates in recycling endosomes (Decressac et al. 2004; Feliciangeli et al. 2007, 2010). A mutant lacking the endocytosis signal redistributes at the plasma membrane, giving recordable current. This mutant allowed a reassessment of the electrophysiological properties of TWIK1 (Chatelain et al. 2012). This work demonstrated that TWIK1 current is increased by mutations that target the pore of the channel without affecting the putative sumoylation site. Recent data show the existence of a hydrophobic barrier within the deep inner pore, the stochastic dewetting of which is a major barrier to ion conduction (Aryal et al. 2014).
Not so silent K2P subunits
Beside TWIK1, other K2P subunits (namely TASK5, KCNK7 and THIK2) have been coined ‘silent’ subunits because of their lack of expression in heterologous systems (Bichet et al. 2015). This raises the question of whether they are non-functional isoforms or functional subunits that require unidentified activators and/or protein partners. This second possibility has been strengthened by the recent demonstration that THIK2 could be turned on by overcoming two silencing mechanisms, retention in the endoplasmic reticulum (ER) and low activity at the plasma membrane (Chatelain et al. 2013; Renigunta et al. 2014b). Inactivation of the ER retention signal allowed the expression of THIK2 at the plasma membrane, enabling its electrophysiological characterization. THIK2 has electrophysiological and pharmacological properties very similar to those of THIK1, including inhibition by halothane and insensitivity to extracellular pH changes. Mutations equivalent to the pore mutations activating TWIK1 were able to activate THIK2, suggesting that THIK2 also contains a hydrophobic barrier in its deep pore (Chatelain et al. 2013). These results suggest that a similar approach may be successful to obtain functional expression of the ‘silent’ TASK5 and KCNK7 K2P subunits.
Homo- and heteromerization of K2P subunits
Further studies showed that THIK2 assembles with THIK1 to form an active channel (Blin et al. 2014). The resulting heterodimer reaches the cell surface and exhibits novel electrophysiological properties, providing evidence that interaction with another subunit can modulate K2P channel activity. Whether such a mechanism also applies to silent TASK5 and KCNK7 subunits remains to be established. THIK1 and THIK2 are not the only K2P subunits able to form active heterodimers. The best-documented case involves TASK1 and TASK3 (Czirják & Enyedi, 2002a; Berg et al. 2004). The resulting heterodimer retains some of the properties of each monomer and exhibits some others that are intermediate. There is a strong physiological relevance because native TASK heterodimers have been reported in different tissues, where they account for a significant part of the leak current (Enyedi & Czirják, 2010). As mentioned before, TWIK1 may also interact with TASK1 and TASK3 subunits in the cerebellum (Plant et al. 2012). Recent data show that in astrocytes TWIK1 and TREK1 form heterodimers that mediate astrocytic passive conductance and cannabinoid-induced glutamate release (Hwang et al. 2014). This result suggests that TWIK1/TREK1 hetero-dimers are permeable to large molecules, such as glutamate. However, the molecular mechanisms underlying this unexpected property are not yet known.
Interacting partners of the K2P channels
Heteromerization is a cost-effective means for a cell to acquire new functions by generating new channels with specific regulations and behaviours. Another way is the modulation of existing channels by auxiliary proteins that can affect different properties, such as channel trafficking or gating. This is well exemplified on TREK1 and TREK2. Indeed, binding of the A-kinase anchoring protein (AKAP)-150 to a major regulatory site adjacent to the M4 domain stimulates TREK1 and TREK2 activity (Sandoz et al. 2006), whereas interaction with microtubule-associated protein 2 (Mtap2) increases recruitment of the channels at the cell surface in a tubulin-dependent manner (Sandoz et al. 2008). Coat protein 1 (COP-I) also promotes TREK1 distribution at the cell surface (Kim et al. 2010) and so does its interaction with the neurotensin receptor (NTR) 3/sortilin, a protein located mostly in the trans-Golgi network and involved in intracellular trafficking (Mazella et al. 2010). On the contrary, the binding of spadin, a peptide derived from the maturation of NTR3/sortilin, causes TREK1 inhibition and internalization. Also, association of TREK1 with the prion protein PrPc has been reported, but its relevance has not been documented yet (Azzalin et al. 2006). Other K2P channels are controlled by interaction with partner proteins. The presence of TASK1 and TASK3 at the plasma membrane is the result of a fine balance between the mutually exclusive binding of COP-I (retrieval to the ER) and 14-3-3 (forward signal; O’Kelly et al. 2002; Zuzarte et al. 2009). TASK1 also interacts with p11; however, the role of this interaction is not clear (Girard et al. 2002; Renigunta et al. 2006). Finally, endosomal SNARE protein syntaxin-8 interacts with TASK1 and promotes its internalization. TWIK1 interacts with a complex made of the small G-protein ARF6 and its nucleotide exchange factor EFA6, which are elements of the internalization machinery. TWIK1 binding to a complex comprising EFA6/ARF6GDP would favour the exchange of GDP by GTP, the recruitment of coat proteins and the constitutive endocytosis of the channel (Decressac et al. 2004). In the case of TRESK, interaction with the calcium/calmodulin-dependent protein phosphatase calcineurin changes its regulation because it provides the channel with sensitivity to intracellular Ca2+ (Czirják et al. 2004). The TRESK channel also interacts with 14-3-3 (Czirják et al. 2008) and tubulin (Enyedi et al. 2014).
Regulation of K2P channels by G-protein-mediated pathways
Signalling pathways related to the activation of G-protein-coupled receptors by hormones and neurotransmitters affect K2P channels in various ways. In some cases, G-protein activation affects cellular trafficking. For instance, activation of Gi-coupled receptors may increase TWIK1 current through relocation of endosomal channels to the cell surface (Feliciangeli et al. 2010). THIK2 ER retention signal contains a consensus protein kinase A site, suggesting that this signalling pathway could be involved in its exit from the ER and relocation to the plasma membrane (Chatelain et al. 2013). More often, G-protein activation directly affects the gating properties of K2P channels. For instance, TRESK–calcineurin interaction causes dephosphorylation and activation of TRESK, hence coupling channel activity to the level of intracellular Ca2+ (Czirják et al. 2004). On the contrary, stimulation of Gq-coupled receptors leads to an inhibition of TASK channels (Chen et al. 2006). TREK1 and TREK2 are inhibited by stimulation of Gq-activated protein kinase C and Gs-activated protein kinase A (Fink et al. 1996; Lesage et al. 2000), although some studies also suggest an effect via the depletion of phosphatidylinositol 4,5-bisphosphate (PIP2) (Lopes et al. 2005). The C-termini of these channels have phosphorylation sites for each kinase, and phosphorylation by one kinase seems to favour the action of the other one (Murbartián et al. 2005; Kang et al. 2006). Another way for G-proteins to modulate K2P activity is by interacting directly with the channels. It has been established that Gβγ can bind directly to the cytoplasmic C-termini of TASK2 and TREK1 with opposite results, i.e. inhibition of TASK2 (Añazco et al. 2013) and opening of TREK1 (Woo et al. 2012).
Effect of lipids and physical parameters
The K2P channels are sensitive to different lipids. For instance, arachidonic acid and other polyunsaturated fatty acids (PUFAs) inhibit TRESK (Sano et al. 2003), whereas they activate TREK1 (Patel et al. 1998), TREK2 (Bang et al. 2000; Lesage et al. 2000) and TRAAK (Fink et al. 1998). Through the production of phosphatidic acid, phospholipase D2 potentiates the activity of TREK1 and TREK2, but not TRAAK (Comoglio et al. 2014). TREK/TRAAK channels are the only K2P channels activated by a mechanical stretch of the membrane. The membrane-spanning helices (primarily M4) and the C-terminal region close to M4 play a pivotal role in this regulation (Patel et al. 1998; Honoré et al. 2002). This mechanical sensitivity does not depend on a tether-mediated mechanism but comes directly from the lipid bilayer (Brohawn et al. 2014). TREK/TRAAK channels are very sensitive to temperature. A 10°C rise enhances TREK1 current amplitude by approximately sevenfold. In cells transfected with TREK2 or TRAAK, a rise from 24 to 42°C causes the whole-cell currents to increase about 20-fold (Maingret et al. 2000a; Kang et al. 2005).
Physiology and pathophysiology of K2P channels
The role of the K2P channels in the control of the membrane potential, and therefore of cellular excitability, mark them as potential players in a number of biological functions. The K2P channels display very diverse expression patterns, from almost ubiquitous, such as TWIK1, to restricted to a subset of cells, such as TALK1, which is almost exclusively expressed in the exocrine pancreas. The field is active for development of drugs targeting K2P channels (Bagriantsev et al. 2013; Rodrigues et al. 2014), and some specific inhibitors have been recently described, such as spadin, which inhibits TREK1 with an affinity in the nanomolar range (Mazella et al. 2010). Nonetheless, tools are still very limited, and this lack has hindered the investigations of the physiological roles of the K2P channels by classical pharmacological approaches. As a consequence, most of the information has come from the study of transgenic animal models, essentially from mice with inactivated KCNK genes (Sabbadini & Yost, 2009). These mice do not show anatomical abnormalities and breed normally. The only exception is TASK2, for which two studies have reported a reduced viability due to increased mortality in the neonatal period (Gerstin et al. 2003; Warth et al. 2004). Subtle alterations in different physiological processes have been reported, some correlated and others causative of a disease (Table2). Here, we will present only a few relevant examples of the studies that link K2P channels to physiopathology. More detailed description can be found elsewhere (e.g. Bayliss & Barrett, 2008; Sabbadini & Yost, 2009; Enyedi & Czirják, 2010; Es-Salah-Lamoureux et al. 2010; Lesage & Barhanin, 2011).
Table 2.
Pathophysiologies of K2P channels deduced from cell, and animal models and implications in human pathologies
![]() |
Superscripts are as follows: 1, Lesage et al. (1996); 2, Nie et al. (2005); 3, Beitzinger et al. (2008); 4, Ma et al. (2011); 5, Chavez et al. (1999); 6, Pountney et al. (1999); 7, Patel et al. (2000); 8, Lloyd et al. (2011); 9, Pandit et al. (2014); 10, Salinas et al. (1999); 11, Yost et al. (2008); 12, Fink et al. (1996); 13, Lauritzen et al. (2005); 14, Heurteaux et al. (2006); 15, Heurteaux et al. (2004); 16, Bittner et al. (2013); 17, Blondeau et al. (2007); 18, Garry et al. (2007); 19, Alloui et al. (2006); 20, Pereira et al. (2014); 21, Noël et al. (2009); 22, Voloshyna et al. (2008); 23, Lesage et al. (2000); 24, Bang et al. (2000); 25, Fink et al. (1998); 26, Laigle et al. (2012); 27, Duprat et al. (1997); 28, Heitzmann et al. (2008); 29, Bittner et al. (2009); 30, Davies et al. (2008); 31, Guagliardo et al. (2012); 32, Penton et al. (2012); 33, Lauritzen et al. (2003); 34, Ma et al. (2013); 35, Liang et al. (2014); 36, Mu et al. (2003); 37, Pei et al. (2003); 38, Kim et al. (2000); 39, Rajan et al. (2000); 40, Linden et al. (2007); 41, Bando et al. (2014); 42, Gotter et al. (2011); 43, Barel et al. (2008); 44, Kim & Gnatenco (2001); 45, Ashmole et al. (2001); 46, Reyes et al. (1998); 47, Warth et al. (2004); 48, Barriere et al. (2003); 49, Bobak et al. (2011); 50, Gestreau et al. (2010); 51, Alvarez-Baron et al. (2011); 52, Girard et al. (2001); 53, Friedrich et al. (2014); 54, Rajan et al. (2001); 55, Sano et al. (2003); 56, Chae et al. (2010); 57, Lafrenière et al. (2010); 58, Maher et al. (2013).
Some phenotypes are directly linked to the regulation or the pharmacological properties of the inactivated channel. For example, knocking out volatile anaesthetic-activated K2P channels TASK1/3 and TREK1 produces an anaesthetic-resistant phenotype (Heurteaux et al. 2004; Linden et al. 2006, 2007). TREK1 sensitivity to PUFAs forms a basis for the neuroprotective effects afforded by PUFAs against cerebral ischaemia (Heurteaux et al. 2004), because opening of the channel by PUFAs would lower cell excitability and excitotoxicity. Likewise, the higher thresholds for thermal and mechanical nociception, as well as hyperalgesia in inflammatory conditions, observed in TREK1 knock-out (KO) mice seem to be associated with the sensitivity of TREK1 to temperature and mechanical stimulation (Alloui et al. 2006; Noël et al. 2009). Indeed, in nociceptor neurons of dorsal root ganglia both types of stimuli activate TREK1, causing hyperpolarization and attenuation of the signal. TREK2 and TRAAK are also involved in mechanical and thermal sensation, with specificities that make the three channels complementary (Pereira et al. 2014). TRESK is also abundant in dorsal root ganglia and other sensory ganglia; hence, it could potentially play a role in nociception. Blocking or silencing the channel was reported to modify nociceptor excitability (Tulleuda et al. 2011), but no phenotype could be observed in the TRESK KO mice (Dobler et al. 2007).
TASK1 and TASK3 are sensitive to pH and are expressed in several nuclei or carotid bodies with chemosensory functions. Therefore a role as sensors of
by sensing acidosis was suspected early on. Using a pharmacological approach as well as single-channel current analysis, it was shown that TASK1, TASK3 and, mostly, TASK1/TASK3 heterodimers play an important role in chemoreception in the carotid bodies, the primary sensors of hypoxia and metabolic acidosis (Buckler et al. 2000; Kim et al. 2009). Data also support a role of TASK channels in the sensitivity of neuroepithelial bodies to
(Hartness et al. 2001). TASK1 and TASK3 are expressed in several nuclei of the brainstem that monitor
but studies, notably on KO models, argue against a role of these channels in central respiratory chemosensitivity (Mulkey et al. 2007).
The role of TALK channels was studied in conditions linked to alkalinization. Data from KO mice suggest that TASK2 is engaged in bicarbonate reabsorption in the kidney and the accompanying Na+ and water movements (Warth et al. 2004). Activation of the channel by HCO3−-mediated alkalization generates a K+ flux that counterbalances the depolarization caused by the Na+–3 HCO3− cotransporter and hence enables the upholding of HCO3− flux (L’Hoste et al. 2007). A similar role has been suggested for TASK2, TALK1 and TALK2 in epithelial cells of the exocrine pancreas, based on their abundant expression in these cells (Fong et al. 2003). Also, TASK2 activation is necessary for volume regulation of native renal proximal tubule cells (Barriere et al. 2003). Finally, TASK2 is expressed in retrotrapezoid nucleus neurons, a population of which is involved in CO2 and O2 sensing, and TASK2 KO mice exhibit alteration in their breathing behaviour following hypoxia or exposure to low CO2 (Gestreau et al. 2010). These data suggest a major role of the TASK2 channel in central O2 chemosensitivity.
Even without stimulation, basal background conductance produced by K2P channels plays a role in cellular excitability and development of different tissues. In the brain, TREK1 participates in serotoninergic transmission, which is increased in TREK1 KO mice (Heurteaux et al. 2006). This affects behaviour, with KO mice displaying a depression-resistant phenotype in a large battery of assays for the evaluation of helplessness and despair. A similar phenotype was observed in mice treated with the TREK1 inhibitor spadin (Moha Ou Maati et al. 2012). These results mark TREK1 as a potential target for antidepressant development (Borsotto et al. 2015). Other effects of TREK1 inactivation have been observed, supporting other roles. For instance, recent data suggest that TREK1 is required for the integrity of the blood–brain barrier (Bittner et al. 2013, 2014). In TREK1 KO mice, leucocyte transmigration is increased in autoimmune encephalomyelitis, an experimental model of blood–brain barrier dysfunction related to inflammation. TREK1 inactivation is associated with aggravated symptoms and increased cellular infiltrates in the central nervous system, whereas TREK1 activation by riluzole or α-linolenic acid attenuates the severity of the symptoms in wild-type animals.
TASK channels are another example of leak K+ channels involved in both cellular excitability and development. In cerebellar granule cells, the spillover of synaptically released GABA gives rise to a persistent inhibitory conductance mediated by the GABAA receptor. However, when this receptor is inactivated, no change is observed in the membrane potential because of a spontaneous compensation by overexpression of TASK1 and TASK3 (Brickley et al. 2001; Aller et al. 2005). In the cerebellum, TASK3 expression correlates with massive neuronal apoptosis during development (Lauritzen et al. 2003). On the contrary, TASK3 overexpression increases cell survival and causes cell proliferation of transformed fibroblasts (Mu et al. 2003). Together, these results suggest that TASK3 plays a dual role in proliferation or apoptosis depending on the context. Surprisingly, TASK3 KO mice display only minor impairment of locomotion. However, they present alterations such as impaired working memory and perturbation in the regulation of the circadian rhythm (Linden et al. 2007), which, together with the resistance of these mice to antidepressants, suggest an involvement of TASK3 in the mechanisms of depression (Gotter et al. 2011). In the hypothalamic orexin neurons, a role in glucose sensing was proposed for TASK channels (Burdakov et al. 2006); however, the function is preserved in TASK1/TASK3 double-KO mice (Guyon et al. 2009; González et al. 2009). In rat adrenal glomerulosa cells, TASK channels are responsible for the high resting conductance, with a major contribution of TASK3 (Czirják et al. 2000; Czirják & Enyedi, 2002b; Lotshaw, 2006). Knock-out of TASK1 or both TASK1 and TASK3 causes primary hyperaldosteronism (Heitzmann et al. 2008; Davies et al. 2008). In TASK1 KO mice, aldosterone overproduction is a consequence of an inappropriate zonation of the adrenal gland (Heitzmann et al. 2008). Only immature mice and females are affected. This points out an unexpected role of TASK1 in the development and zonation of the adrenal cortex. It also shows that for this function, TASK3 cannot compensate for the absence of TASK1. The predominant role of TASK1 is also attested in human adrenal glands (Nogueira et al. 2010). In bovine tissue, the role in aldosterone secretion appears to be played by TREK1 (Enyeart et al. 2004). In the heart, TASK1 is predominantly expressed in the ventricle in rodents, and KO mice show a ventricular phenotype with prolonged QT interval, wide QRS and increased ventricular action potential duration (Decher et al. 2011; Donner et al. 2011). In humans, however, TASK1 is mostly found in the atria, leading to the proposal that it could be involved in atrial fibrillation. This possibility is strengthened by the fact that mutations found in patients with atrial fibrillation alter atrial TASK1 current in zebrafish (Liang et al. 2014). TWIK2 is highly expressed in the vascular system, and inactivation of its gene is associated with vascular and pulmonary hypertension (Lloyd et al. 2011; Pandit et al. 2014). In astrocytes (Wang et al. 2013), renal cells (Millar et al. 2006) and pancreatic β-cells (Chatelain et al. 2012), TWIK1 gene inactivation causes hyperpolarization of the resting membrane potential, which is explained by the dynamic ion selectivity of the channel.
K2P channels in human pathologies
Dynamic ion selectivity of TWIK1 can account for the paradoxical depolarization of human cardiomyocytes observed in subphysiological K+, a phenomenon that may give rise to cardiac arrhythmias (Chen et al. 2014). A dominant-negative mutation in the gene encoding TRESK segregates with a phenotype of migraine with aura (Lafrenière et al. 2010). However, another loss-of-function mutation of TRESK could not be associated with the phenotype (Maher et al. 2013), suggesting a multigenic origin of this hereditary disease.
The relationship with a genetic disorder is more straightforward for other K2P channels. In humans, whole-exome sequencing of multiple patients with pulmonary arterial hypertension has revealed a correlation between the pathology and several missense mutations, all of which abolish TASK1 activity (Ma et al. 2013). This fits well with the reports that TASK1 is sensitive to hypoxia and plays a role in the regulation of the pulmonary vascular tone (Gurney et al. 2003). Genome studies revealed that TASK3 is genetically imprinted, i.e. it is expressed only from the maternal allele, and that a missense mutation (G236R) is associated with the Birk–Barel syndrom, a maternally transmitted syndrome of mental retardation, hypotonia and unique dysmorphism with elongated face (Barel et al. 2008). The original study reported that the mutation produces a dominant-negative TASK3 subunit, resulting in non-functional TASK3 homodimers and TASK1/TASK3 hetetrodimers (Barel et al. 2008). However, others have described that the mutated subunit still produces current, although significantly decreased and with altered properties (Veale et al. 2014). In a patient with a severe cardiac phenotype of cardiac arrhythmia, in addition to a mutation in the cardiac sodium channel SCN5A, another mutation was identified in the M1P1 loop of TALK2 (G88R) that causes a gain of function and an increase of the channel conductance (Friedrich et al. 2014). This increased activity is likely to promote repolarization of the cardiac action potential and to shorten refractory period, which might therefore favour re-entry arrhythmias. This example illustrates the need for a tight control of K2P channel activity within physiological margins. TASK3 is another example. In cell and animal models, TASK3 has been demonstrated to be involved in both cell apoptosis and survival. As mentioned above, the channel is associated both with massive apoptosis in the developing cerebellum and with survival and proliferation when overexpressed in fibroblasts (Mu et al. 2003; Lauritzen et al. 2003). This suggests that this channel could play different roles depending on its regulation and, therefore, that TASK3 could shift from one function to the other upon a change in its environment, with potential physiopathological consequences. Along this line, overexpression of the channel has been reported in many different types of human cancers (Mu et al. 2003).
In fact, all but three K2P channels (TRAAK, TALK1 and TRESK) have their expression modified in different oncogenic processes (Williams et al. 2013). For instance, TWIK1 is among the top 1% of genes with altered expression in different types of human cancers, either increased (bladder, lung and pancreas) or decreased (cancers of the central nervous system). Its expression varies in ovarian and prostate cancers, decreasing with tumour progression. Likewise, TREK exhibits modified expression in a variety of cancer types, such as lung or brain cancers. Although it was demonstrated in some cases that the activity of the channel is required in order to observe the oncogenic effect (Pei et al. 2003), more work is necessary to conclude whether altered expression is a cause or a consequence of the carcinogenesis.
Conclusions
Since the serendipitous identification of TWIK1 in 1996, we have learned a lot about the diversity and nature of K2P channels. Far from forming mere K+ leaks in the plasma membrane, they have proved to be exquisitely regulated by a wide variety of mechanisms. The K2P channels affect cell excitability and biology and are involved in the normal development and functioning of many tissues, including brain, heart, adrenal glands and kidneys. This field of research continues to evolve rapidly, constantly improving our understanding of the physiological and pathological roles of the K2P channels. New, fascinating questions emerge from recent data. The studies on ‘silent’ channels suggest that some of these K2P channels may have a role in intracellular compartments (TWIK1 in recycling endosomes and THIK2 and KCNK7 in the ER), and the presence of a hydrophobic barrier in the deep pore of some of them supports the existence of a new type of gate. How and by which stimuli this hydrophobic gate is controlled remain open questions. By suggesting that K+ channels may fulfil inhibitory and excitatory roles traditionally attributed to distinct classes of ion channels, the recent demonstration that TWIK1 exhibits dynamic ion selectivity opens new areas of research. Which K2P channels exhibit this behaviour, which stimuli can influence their ionic selectivity, and what the impacts are on cell biology constitute fascinating interrogations. Finally, the therapeutic interest in these K2P channels is important. Drugs targeting K2P channels may be relevant for treating disorders as diverse as depression, pain, vascular and pulmonary hypertension and cancer.
Glossary
- ER
endoplasmic reticulum
- Kir
inward rectifier potassium channel
- KO
knock-out
- K2P channel
two-pore-domain potassium channel
- Kv channel
voltage-gated K+ channel
- LP
lysophospholipid
- PUFA
polyunsaturated fatty acid
Biography
Sylvain Feliciangeli received his PhD in Cellular and Molecular Pharmacology from the University of Nice-Sophia Antipolis with Dr Patrick Kitabgi. After a post-doctoral stay at the Vollum Institute (OHSU, OR) in the laboratory of Dr Gary Thomas, he joined Dr Lesage team where he studies the cell biology of K2P channels as a senior scientist. Florian Lesage received his PhD in Life Sciences from the University of Nice-Sophia Antipolis, France. He was a visiting scientist in Pr A. James Hudspeth laboratory at the RockfellerUniversity.He is now Research Director and leads a team that studiesmammalian K2P channels that he has originally identified in the laboratory of Pr Michel Lazdunski.
Additional information
Competing interests
None declared.
Funding
The authors are supported by the Fondation pour la Recherche Médicale (Equipe labellisée FRM 2011) and by the French Government (National Research Agency, ANR) through the ‘Investments for the Future’ Program, grant ANR-11-LABX-0015-01.
References
- Aller MI, Veale EL, Linden A-M, Sandu C, Schwaninger M, Evans LJ, Korpi ER, Mathie A, Wisden W. Brickley SG. Modifying the subunit composition of TASK channels alters the modulation of a leak conductance in cerebellar granule neurons. J Neurosci. 2005;25:11455–11467. doi: 10.1523/JNEUROSCI.3153-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alloui A, Zimmermann K, Mamet J, Duprat F, Noël J, Chemin J, Guy N, Blondeau N, Voilley N, Rubat-Coudert C, Borsotto M, Romey G, Heurteaux C, Reeh P, Eschalier A. Lazdunski M. TREK-1, a K+ channel involved in polymodal pain perception. EMBO J. 2006;25:2368–2376. doi: 10.1038/sj.emboj.7601116. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Alvarez-Baron CP, Jonsson P, Thomas C, Dryer SE. Williams C. The two-pore domain potassium channel KCNK5: induction by estrogen receptor α and role in proliferation of breast cancer cells. Mol Endocrinol. 2011;25:1326–1336. doi: 10.1210/me.2011-0045. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Añazco C, Peña-Münzenmayer G, Araya C, Cid LP, Sepúlveda FV. Niemeyer MI. G protein modulation of K2P potassium channel TASK-2: a role of basic residues in the C terminus domain. Pflugers Arch. 2013;465:1715–1726. doi: 10.1007/s00424-013-1314-0. [DOI] [PubMed] [Google Scholar]
- Aryal P, Abd-Wahab F, Bucci G, Sansom MSP. Tucker SJ. A hydrophobic barrier deep within the inner pore of the TWIK-1 K2P potassium channel. Nat Commun. 2014;5:4377. doi: 10.1038/ncomms5377. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ashmole I, Goodwin PA. Stanfield PR. TASK-5, a novel member of the tandem pore K+ channel family. Pflugers Arch. 2001;442:828–833. doi: 10.1007/s004240100620. [DOI] [PubMed] [Google Scholar]
- Azzalin A, Ferrara V, Arias A, Cerri S, Avella D, Pisu MB, Nano R, Bernocchi G, Ferretti L. Comincini S. Interaction between the cellular prion (PrPC) and the 2P domain K+ channel TREK-1 protein. Biochem Biophys Res Commun. 2006;346:108–115. doi: 10.1016/j.bbrc.2006.05.097. [DOI] [PubMed] [Google Scholar]
- Bagriantsev SN, Ang K-H, Gallardo-Godoy A, Clark KA, Arkin MR, Renslo AR. Minor DL., Jr A high-throughput functional screen identifies small molecule regulators of temperature- and mechano-sensitive K2P channels. ACS Chem Biol. 2013;8:1841–1851. doi: 10.1021/cb400289x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bagriantsev SN, Clark KA. Minor DL., Jr Metabolic and thermal stimuli control K2P2.1 (TREK-1) through modular sensory and gating domains. EMBO J. 2012;31:3297–3308. doi: 10.1038/emboj.2012.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bagriantsev SN, Peyronnet R, Clark KA, Honoré E. Minor DL., Jr Multiple modalities converge on a common gate to control K2P channel function. EMBO J. 2011;30:3594–3606. doi: 10.1038/emboj.2011.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bando Y, Hirano T. Tagawa Y. Dysfunction of KCNK potassium channels impairs neuronal migration in the developing mouse cerebral cortex. Cereb Cortex. 2014;24:1017–1029. doi: 10.1093/cercor/bhs387. [DOI] [PubMed] [Google Scholar]
- Bang H, Kim Y. Kim D. TREK-2, a new member of the mechanosensitive tandem-pore K+ channel family. J Biol Chem. 2000;275:17412–17419. doi: 10.1074/jbc.M000445200. [DOI] [PubMed] [Google Scholar]
- Barel O, Shalev SA, Ofir R, Cohen A, Zlotogora J, Shorer Z, Mazor G, Finer G, Khateeb S, Zilberberg N. Birk OS. Maternally inherited Birk Barel mental retardation dysmorphism syndrome caused by a mutation in the genomically imprinted potassium channel KCNK9. Am J Hum Genet. 2008;83:193–199. doi: 10.1016/j.ajhg.2008.07.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Barriere H, Belfodil R, Rubera I, Tauc M, Lesage F, Poujeol C, Guy N, Barhanin J. Poujeol P. Role of TASK2 potassium channels regarding volume regulation in primary cultures of mouse proximal tubules. J Gen Physiol. 2003;122:177–190. doi: 10.1085/jgp.200308820. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bautista DM, Sigal YM, Milstein AD, Garrison JL, Zorn JA, Tsuruda PR, Nicoll RA. Julius D. Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels. Nat Neurosci. 2008;11:772–779. doi: 10.1038/nn.2143. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bayliss DA. Barrett PQ. Emerging roles for two-pore-domain potassium channels and their potential therapeutic impact. Trends Pharmacol Sci. 2008;29:566–575. doi: 10.1016/j.tips.2008.07.013. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Beitzinger M, Hofmann L, Oswald C, Beinoraviciute-Kellner R, Sauer M, Griesmann H, Bretz AC, Burek C, Rosenwald A. Stiewe T. p73 poses a barrier to malignant transformation by limiting anchorage-independent growth. EMBO J. 2008;27:792–803. doi: 10.1038/emboj.2008.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Berg AP, Talley EM, Manger JP. Bayliss DA. Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits. J Neurosci. 2004;24:6693–6702. doi: 10.1523/JNEUROSCI.1408-04.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bichet D, Blin S, Feliciangeli S, Chatelain FC, Bobak N. Lesage F. Silent but not dumb: how cellular trafficking and pore gating modulate expression of TWIK1 and THIK2. Pflugers Arch. 2015 doi: 10.1007/s00424-014-1631-y. ; in press. [DOI] [PubMed] [Google Scholar]
- Bittner S, Meuth SG, Göbel K, Melzer N, Herrmann AM, Simon OJ, Weishaupt A, Budde T, Bayliss DA, Bendszus M. Wiendl H. TASK1 modulates inflammation and neurodegeneration in autoimmune inflammation of the central nervous system. Brain. 2009;132:2501–2516. doi: 10.1093/brain/awp163. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bittner S, Ruck T, Fernández-Orth J. Meuth SG. TREK-king the blood–brain-barrier. J Neuroimmune Pharmacol. 2014;9:293–301. doi: 10.1007/s11481-014-9530-8. [DOI] [PubMed] [Google Scholar]
- Bittner S, Ruck T, Schuhmann MK, Herrmann AM, Moha ou Maati H, Bobak N, Göbel K, Langhauser F, Stegner D, Ehling P, Borsotto M, Pape H-C, Nieswandt B, Kleinschnitz C, Heurteaux C, Galla H-J, Budde T, Wiendl H. Meuth SG. Endothelial TWIK-related potassium channel-1 (TREK1) regulates immune-cell trafficking into the CNS. Nat Med. 2013;19:1161–1165. doi: 10.1038/nm.3303. [DOI] [PubMed] [Google Scholar]
- Blin S, Chatelain FC, Feliciangeli S, Kang D, Lesage F. Bichet D. Tandem pore domain halothane-inhibited K+ channel subunits THIK1 and THIK2 assemble and form active channels. J Biol Chem. 2014;289:28202–28212. doi: 10.1074/jbc.M114.600437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Blondeau N, Pétrault O, Manta S, Giordanengo V, Gounon P, Bordet R, Lazdunski M. Heurteaux C. Polyunsaturated fatty acids are cerebral vasodilators via the TREK-1 potassium channel. Circ Res. 2007;101:176–184. doi: 10.1161/CIRCRESAHA.107.154443. [DOI] [PubMed] [Google Scholar]
- Bobak N, Bittner S, Andronic J, Hartmann S, Mühlpfordt F, Schneider-Hohendorf T, Wolf K, Schmelter C, Göbel K, Meuth P, Zimmermann H, Döring F, Wischmeyer E, Budde T, Wiendl H, Meuth SG. Sukhorukov VL. Volume regulation of murine T lymphocytes relies on voltage-dependent and two-pore domain potassium channels. Biochim Biophys Acta. 2011;1808:2036–2044. doi: 10.1016/j.bbamem.2011.04.013. [DOI] [PubMed] [Google Scholar]
- Bockenhauer D, Zilberberg N. Goldstein SAN. KCNK2: reversible conversion of a hippocampal potassium leak into a voltage-dependent channel. Nat Neurosci. 2001;4:486–491. doi: 10.1038/87434. [DOI] [PubMed] [Google Scholar]
- Borsotto M, Veyssiere J, Moha Ou Maati H, Devader C, Mazella J. Heurteaux C. Targeting two pore domain K+ channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutical concept. Br J Pharmacol. 2015;172:771–784. doi: 10.1111/bph.12953. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brickley SG, Revilla V, Cull-Candy SG, Wisden W. Farrant M. Adaptive regulation of neuronal excitability by a voltage-independent potassium conductance. Nature. 2001;409:88–92. doi: 10.1038/35051086. [DOI] [PubMed] [Google Scholar]
- Brohawn SG, del Mármol J. MacKinnon R. Crystal structure of the human K2P TRAAK, a lipid- and mechano-sensitive K+ ion channel. Science. 2012;335:436–441. doi: 10.1126/science.1213808. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Brohawn SG, Su Z. MacKinnon R. Mechanosensitivity is mediated directly by the lipid membrane in TRAAK and TREK1 K+ channels. Proc Natl Acad Sci U S A. 2014;111:3614–3619. doi: 10.1073/pnas.1320768111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buckler KJ, Williams BA. Honore E. An oxygen-, acid- and anaesthetic-sensitive TASK-like background potassium channel in rat arterial chemoreceptor cells. J Physiol. 2000;525:135–142. doi: 10.1111/j.1469-7793.2000.00135.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Burdakov D, Jensen LT, Alexopoulos H, Williams RH, Fearon IM, O’Kelly I, Gerasimenko O, Fugger L. Verkhratsky A. Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron. 2006;50:711–722. doi: 10.1016/j.neuron.2006.04.032. [DOI] [PubMed] [Google Scholar]
- Campanucci VA, Brown ST, Hudasek K, O’Kelly IM, Nurse CA. Fearon IM. O2 sensing by recombinant TWIK-related halothane-inhibitable K+ channel-1 background K+ channels heterologously expressed in human embryonic kidney cells. Neuroscience. 2005;135:1087–1094. doi: 10.1016/j.neuroscience.2005.07.009. [DOI] [PubMed] [Google Scholar]
- Chae YJ, Zhang J, Au P, Sabbadini M, Xie G-X. Yost CS. Discrete change in volatile anesthetic sensitivity in mice with inactivated tandem pore potassium ion channel TRESK. Anesthesiology. 2010;113:1326–1337. doi: 10.1097/ALN.0b013e3181f90ca5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chatelain FC, Bichet D, Douguet D, Feliciangeli S, Bendahhou S, Reichold M, Warth R, Barhanin J. Lesage F. TWIK1, a unique background channel with variable ion selectivity. Proc Natl Acad Sci U S A. 2012;109:5499–5504. doi: 10.1073/pnas.1201132109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chatelain FC, Bichet D, Feliciangeli S, Larroque M-M, Braud VM, Douguet D. Lesage F. Silencing of the tandem pore domain halothane-inhibited K+ channel 2 (THIK2) relies on combined intracellular retention and low intrinsic activity at the plasma membrane. J Biol Chem. 2013;288:35081–35092. doi: 10.1074/jbc.M113.503318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chavez RA, Gray AT, Zhao BB, Kindler CH, Mazurek MJ, Mehta Y, Forsayeth JR. Yost CS. TWIK-2, a new weak inward rectifying member of the tandem pore domain potassium channel family. J Biol Chem. 1999;274:7887–7892. doi: 10.1074/jbc.274.12.7887. [DOI] [PubMed] [Google Scholar]
- Chen H, Chatelain FC. Lesage F. Altered and dynamic ion selectivity of K+ channels in cell development and excitability. Trends Pharmacol Sci. 2014;35:461–469. doi: 10.1016/j.tips.2014.06.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chen X, Talley EM, Patel N, Gomis A, McIntire WE, Dong B, Viana F, Garrison JC. Bayliss DA. Inhibition of a background potassium channel by Gq protein α-subunits. Proc Natl Acad Sci U S A. 2006;103:3422–3427. doi: 10.1073/pnas.0507710103. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen A, Ben-Abu Y, Hen S. Zilberberg N. A novel mechanism for human K2P2.1 channel gating facilitation of C-type gating by protonation of extracellular histidine residues. J Biol Chem. 2008;283:19448–19455. doi: 10.1074/jbc.M801273200. [DOI] [PubMed] [Google Scholar]
- Comoglio Y, Levitz J, Kienzler MA, Lesage F, Isacoff EY. Sandoz G. Phospholipase D2 specifically regulates TREK potassium channels via direct interaction and local production of phosphatidic acid. Proc Natl Acad Sci U S A. 2014;111:13547–13552. doi: 10.1073/pnas.1407160111. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Czirják G. Enyedi P. a Formation of functional heterodimers between the TASK-1 and TASK-3 two-pore domain potassium channel subunits. J Biol Chem. 2002;277:5426–5432. doi: 10.1074/jbc.M107138200. [DOI] [PubMed] [Google Scholar]
- Czirják G. Enyedi P. b TASK-3 dominates the background potassium conductance in rat adrenal glomerulosa cells. Mol Endocrinol. 2002;16:621–629. doi: 10.1210/mend.16.3.0788. [DOI] [PubMed] [Google Scholar]
- Czirják G, Fischer T, Spät A, Lesage F. Enyedi P. TASK (TWIK-related acid-sensitive K+ channel) is expressed in glomerulosa cells of rat adrenal cortex and inhibited by angiotensin II. Mol Endocrinol. 2000;14:863–874. doi: 10.1210/mend.14.6.0466. [DOI] [PubMed] [Google Scholar]
- Czirják G, Tóth ZE. Enyedi P. The two-pore domain K+ channel, TRESK, is activated by the cytoplasmic calcium signal through calcineurin. J Biol Chem. 2004;279:18550–18558. doi: 10.1074/jbc.M312229200. [DOI] [PubMed] [Google Scholar]
- Czirják G, Vuity D. Enyedi P. Phosphorylation-dependent binding of 14-3-3 proteins controls TRESK regulation. J Biol Chem. 2008;283:15672–15680. doi: 10.1074/jbc.M800712200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Davies LA, Hu C, Guagliardo NA, Sen N, Chen X, Talley EM, Carey RM, Bayliss DA. Barrett PQ. TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci U S A. 2008;105:2203–2208. doi: 10.1073/pnas.0712000105. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Decher N, Wemhöner K, Rinné S, Netter MF, Zuzarte M, Aller MI, Kaufmann SG, Li XT, Meuth SG, Daut J, Sachse FB. Maier SKG. Knock-out of the potassium channel TASK-1 leads to a prolonged QT interval and a disturbed QRS complex. Cell Physiol Biochem. 2011;28:77–86. doi: 10.1159/000331715. [DOI] [PubMed] [Google Scholar]
- Decressac S, Franco M, Bendahhou S, Warth R, Knauer S, Barhanin J, Lazdunski M. Lesage F. ARF6-dependent interaction of the TWIK1 K+ channel with EFA6, a GDP/GTP exchange factor for ARF6. EMBO Rep. 2004;5:1171–1175. doi: 10.1038/sj.embor.7400292. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dobler T, Springauf A, Tovornik S, Weber M, Schmitt A, Sedlmeier R, Wischmeyer E. Döring F. TRESK two-pore-domain K+ channels constitute a significant component of background potassium currents in murine dorsal root ganglion neurones. J Physiol. 2007;585:867–879. doi: 10.1113/jphysiol.2007.145649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donner BC, Schullenberg M, Geduldig N, Hüning A, Mersmann J, Zacharowski K, Kovacevic A, Decking U, Aller MI. Schmidt KG. Functional role of TASK-1 in the heart: studies in TASK-1-deficient mice show prolonged cardiac repolarization and reduced heart rate variability. Basic Res Cardiol. 2011;106:75–87. doi: 10.1007/s00395-010-0128-x. [DOI] [PubMed] [Google Scholar]
- Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT. MacKinnon R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998;280:69–77. doi: 10.1126/science.280.5360.69. [DOI] [PubMed] [Google Scholar]
- Duprat F, Girard C, Jarretou G. Lazdunski M. Pancreatic two P domain K+ channels TALK-1 and TALK-2 are activated by nitric oxide and reactive oxygen species. J Physiol. 2005;562:235–244. doi: 10.1113/jphysiol.2004.071266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duprat F, Lesage F, Fink M, Reyes R, Heurteaux C. Lazdunski M. TASK, a human background K+ channel to sense external pH variations near physiological pH. EMBO J. 1997;16:5464–5471. doi: 10.1093/emboj/16.17.5464. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Duprat F, Lesage F, Patel AJ, Fink M, Romey G. Lazdunski M. The neuroprotective agent riluzole activates the two P domain K+ channels TREK-1 and TRAAK. Mol Pharmacol. 2000;57:906–912. [PubMed] [Google Scholar]
- Enyeart JA, Danthi SJ. Enyeart JJ. TREK-1 K+ channels couple angiotensin II receptors to membrane depolarization and aldosterone secretion in bovine adrenal glomerulosa cells. Am J Physiol Endocrinol Metab. 2004;287:E1154–E1165. doi: 10.1152/ajpendo.00223.2004. [DOI] [PubMed] [Google Scholar]
- Enyedi P, Braun G. Czirják G. TRESK: the lone ranger of two-pore domain potassium channels. Mol Cell Endocrinol. 2012;353:75–81. doi: 10.1016/j.mce.2011.11.009. [DOI] [PubMed] [Google Scholar]
- Enyedi P. Czirják G. Molecular background of leak K+ currents: two-pore domain potassium channels. Physiol Rev. 2010;90:559–605. doi: 10.1152/physrev.00029.2009. [DOI] [PubMed] [Google Scholar]
- Enyedi P, Veres I, Braun G. Czirják G. Tubulin binds to the cytoplasmic loop of TRESK background K+ channel in vitro. PloS One. 2014;9:e97854. doi: 10.1371/journal.pone.0097854. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Es-Salah-Lamoureux Z, Steele DF. Fedida D. Research into the therapeutic roles of two-pore-domain potassium channels. Trends Pharmacol Sci. 2010;31:587–595. doi: 10.1016/j.tips.2010.09.001. [DOI] [PubMed] [Google Scholar]
- Feliciangeli S, Bendahhou S, Sandoz G, Gounon P, Reichold M, Warth R, Lazdunski M, Barhanin J. Lesage F. Does sumoylation control K2P1/TWIK1 background K+ channels? Cell. 2007;130:563–569. doi: 10.1016/j.cell.2007.06.012. [DOI] [PubMed] [Google Scholar]
- Feliciangeli S, Tardy MP, Sandoz G, Chatelain FC, Warth R, Barhanin J, Bendahhou S. Lesage F. Potassium channel silencing by constitutive endocytosis and intracellular sequestration. J Biol Chem. 2010;285:4798–4805. doi: 10.1074/jbc.M109.078535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fink M, Duprat F, Lesage F, Reyes R, Romey G, Heurteaux C. Lazdunski M. Cloning, functional expression and brain localization of a novel unconventional outward rectifier K+ channel. EMBO J. 1996;15:6854–6862. [PMC free article] [PubMed] [Google Scholar]
- Fink M, Lesage F, Duprat F, Heurteaux C, Reyes R, Fosset M. Lazdunski M. A neuronal two P domain K+ channel stimulated by arachidonic acid and polyunsaturated fatty acids. EMBO J. 1998;17:3297–3308. doi: 10.1093/emboj/17.12.3297. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fong P, Argent BE, Guggino WB. Gray MA. Characterization of vectorial chloride transport pathways in the human pancreatic duct adenocarcinoma cell line HPAF. Am J Physiol Cell Physiol. 2003;285:C433–C445. doi: 10.1152/ajpcell.00509.2002. [DOI] [PubMed] [Google Scholar]
- Franks NP. Lieb WR. Volatile general anaesthetics activate a novel neuronal K+ current. Nature. 1988;333:662–664. doi: 10.1038/333662a0. [DOI] [PubMed] [Google Scholar]
- Friedrich C, Rinné S, Zumhagen S, Kiper AK, Silbernagel N, Netter MF, Stallmeyer B, Schulze-Bahr E. Decher N. Gain-of-function mutation in TASK-4 channels and severe cardiac conduction disorder. EMBO Mol Med. 2014;6:937–951. doi: 10.15252/emmm.201303783. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Garry A, Fromy B, Blondeau N, Henrion D, Brau F, Gounon P, Guy N, Heurteaux C, Lazdunski M. Saumet JL. Altered acetylcholine, bradykinin and cutaneous pressure-induced vasodilation in mice lacking the TREK1 potassium channel: the endothelial link. EMBO Rep. 2007;8:354–359. doi: 10.1038/sj.embor.7400916. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gerstin KM, Gong DH, Abdallah M, Winegar BD, Eger EI. Gray AT. Mutation of KCNK5 or Kir3.2 potassium channels in mice does not change minimum alveolar anesthetic concentration. Anesth Analg. 2003;96:1345–1349. doi: 10.1213/01.ANE.0000056921.15974.EC. , table of contents. [DOI] [PubMed] [Google Scholar]
- Gestreau C, Heitzmann D, Thomas J, Dubreuil V, Bandulik S, Reichold M, Bendahhou S, Pierson P, Sterner C, Peyronnet-Roux J, Benfriha C, Tegtmeier I, Ehnes H, Georgieff M, Lesage F, Brunet J-F, Goridis C, Warth R. Barhanin J. Task2 potassium channels set central respiratory CO2 and O2 sensitivity. Proc Natl Acad Sci U S A. 2010;107:2325–2330. doi: 10.1073/pnas.0910059107. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Girard C, Duprat F, Terrenoire C, Tinel N, Fosset M, Romey G, Lazdunski M. Lesage F. Genomic and functional characteristics of novel human pancreatic 2P domain K+ channels. Biochem Biophys Res Commun. 2001;282:249–256. doi: 10.1006/bbrc.2001.4562. [DOI] [PubMed] [Google Scholar]
- Girard C, Tinel N, Terrenoire C, Romey G, Lazdunski M. Borsotto M. p11, an annexin II subunit, an auxiliary protein associated with the background K+ channel, TASK-1. EMBO J. 2002;21:4439–4448. doi: 10.1093/emboj/cdf469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Goldstein SAN, Bayliss DA, Kim D, Lesage F, Plant LD. Rajan S. International union of pharmacology. LV. Nomenclature and molecular relationships of two-P potassium channels. Pharmacol Rev. 2005;57:527–540. doi: 10.1124/pr.57.4.12. [DOI] [PubMed] [Google Scholar]
- González C, Baez-Nieto D, Valencia I, Oyarzún I, Rojas P, Naranjo D. Latorre R. K+ channels: function-structural overview. Compr Physiol. 2012;2:2087–2149. doi: 10.1002/cphy.c110047. [DOI] [PubMed] [Google Scholar]
- González JA, Jensen LT, Doyle SE, Miranda-Anaya M, Menaker M, Fugger L, Bayliss DA. Burdakov D. Deletion of TASK1 and TASK3 channels disrupts intrinsic excitability but does not abolish glucose or pH responses of orexin/hypocretin neurons. Eur J Neurosci. 2009;30:57–64. doi: 10.1111/j.1460-9568.2009.06789.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gotter AL, Santarelli VP, Doran SM, Tannenbaum PL, Kraus RL, Rosahl TW, Meziane H, Montial M, Reiss DR, Wessner K, McCampbell A, Stevens J, Brunner JI, Fox SV, Uebele VN, Bayliss DA, Winrow CJ. Renger JJ. TASK-3 as a potential antidepressant target. Brain Res. 2011;1416:69–79. doi: 10.1016/j.brainres.2011.08.021. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gruss M, Mathie A, Lieb WR. Franks NP. The two-pore-domain K+ channels TREK-1 and TASK-3 are differentially modulated by copper and zinc. Mol Pharmacol. 2004;66:530–537. doi: 10.1124/mol.66.3.. [DOI] [PubMed] [Google Scholar]
- Gu W, Schlichthörl G, Hirsch JR, Engels H, Karschin C, Karschin A, Derst C, Steinlein OK. Daut J. Expression pattern and functional characteristics of two novel splice variants of the two-pore-domain potassium channel TREK-2. J Physiol. 2002;539:657–668. doi: 10.1113/jphysiol.2001.013432. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Guagliardo NA, Yao J, Hu C, Schertz EM, Tyson DA, Carey RM, Bayliss DA. Barrett PQ. TASK-3 channel deletion in mice recapitulates low-renin essential hypertension. Hypertension. 2012;59:999–1005. doi: 10.1161/HYPERTENSIONAHA.111.189662. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gurney AM, Osipenko ON, MacMillan D, McFarlane KM, Tate RJ. Kempsill FEJ. Two-pore domain K channel, TASK-1, in pulmonary artery smooth muscle cells. Circ Res. 2003;93:957–964. doi: 10.1161/01.RES.0000099883.68414.61. [DOI] [PubMed] [Google Scholar]
- Gutman GA, Chandy KG, Grissmer S, Lazdunski M, McKinnon D, Pardo LA, Robertson GA, Rudy B, Sanguinetti MC, Stühmer W. Wang X. International union of pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol Rev. 2005;57:473–508. doi: 10.1124/pr.57.4.10. [DOI] [PubMed] [Google Scholar]
- Guyon A, Tardy MP, Rovère C, Nahon J-L, Barhanin J. Lesage F. Glucose inhibition persists in hypothalamic neurons lacking tandem-pore K+ channels. J Neurosci. 2009;29:2528–2533. doi: 10.1523/JNEUROSCI.5764-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartness ME, Lewis A, Searle GJ, O’Kelly I, Peers C. Kemp PJ. Combined antisense and pharmacological approaches implicate hTASK as an airway O2 sensing K+ channel. J Biol Chem. 2001;276:26499–26508. doi: 10.1074/jbc.M010357200. [DOI] [PubMed] [Google Scholar]
- Heitzmann D, Derand R, Jungbauer S, Bandulik S, Sterner C, Schweda F, El Wakil A, Lalli E, Guy N, Mengual R, Reichold M, Tegtmeier I, Bendahhou S, Gomez-Sanchez CE, Aller MI, Wisden W, Weber A, Lesage F, Warth R. Barhanin J. Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis. EMBO J. 2008;27:179–187. doi: 10.1038/sj.emboj.7601934. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heurteaux C, Guy N, Laigle C, Blondeau N, Duprat F, Mazzuca M, Lang-Lazdunski L, Widmann C, Zanzouri M, Romey G. Lazdunski M. TREK-1, a K+ channel involved in neuroprotection and general anesthesia. EMBO J. 2004;23:2684–2695. doi: 10.1038/sj.emboj.7600234. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heurteaux C, Lucas G, Guy N, El Yacoubi M, Thümmler S, Peng X-D, Noble F, Blondeau N, Widmann C, Borsotto M, Gobbi G, Vaugeois J-M, Debonnel G. Lazdunski M. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat Neurosci. 2006;9:1134–1141. doi: 10.1038/nn1749. [DOI] [PubMed] [Google Scholar]
- Honoré E, Maingret F, Lazdunski M. Patel AJ. An intracellular proton sensor commands lipid- and mechano-gating of the K+ channel TREK-1. EMBO J. 2002;21:2968–2976. doi: 10.1093/emboj/cdf288. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hwang EM, Kim E, Yarishkin O, Woo DH, Han K-S, Park N, Bae Y, Woo J, Kim D, Park M, Lee CJ. Park J-Y. A disulphide-linked heterodimer of TWIK-1 and TREK-1 mediates passive conductance in astrocytes. Nat Commun. 2014;5:3227. doi: 10.1038/ncomms4227. [DOI] [PubMed] [Google Scholar]
- Kang D, Choe C, Cavanaugh E. Kim D. Properties of single two-pore domain TREK-2 channels expressed in mammalian cells. J Physiol. 2007;583:57–69. doi: 10.1113/jphysiol.2007.136150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kang D, Choe C. Kim D. Thermosensitivity of the two-pore domain K+ channels TREK-2 and TRAAK. J Physiol. 2005;564:103–116. doi: 10.1113/jphysiol.2004.081059. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kang D, Han J. Kim D. Mechanism of inhibition of TREK-2 (K2P10.1) by the Gq-coupled M3 muscarinic receptor. Am J Physiol Cell Physiol. 2006;291:C649–C656. doi: 10.1152/ajpcell.00047.2006. [DOI] [PubMed] [Google Scholar]
- Kang D. Kim D. Single-channel properties and pH sensitivity of two-pore domain K+ channels of the TALK family. Biochem Biophys Res Commun. 2004;315:836–844. doi: 10.1016/j.bbrc.2004.01.137. [DOI] [PubMed] [Google Scholar]
- Kang D, Kim E-J. Han J. Direct inhibitory effect of fluoxetine on TREK-2 channel. Biophys J. 2012;102:680a. [Google Scholar]
- Kemp PJ, Peers C, Lewis A. Miller P. Regulation of recombinant human brain tandem P domain K+ channels by hypoxia: a role for O2 in the control of neuronal excitability? J Cell Mol Med. 2004;8:38–44. doi: 10.1111/j.1582-4934.2004.tb00258.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kennard LE, Chumbley JR, Ranatunga KM, Armstrong SJ, Veale EL. Mathie A. Inhibition of the human two-pore domain potassium channel, TREK-1, by fluoxetine and its metabolite norfluoxetine. Br J Pharmacol. 2005;144:821–829. doi: 10.1038/sj.bjp.0706068. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim Y, Bang H, Gnatenco C. Kim D. Synergistic interaction and the role of C-terminus in the activation of TRAAK K+ channels by pressure, free fatty acids and alkali. Pflugers Arch. 2001;442:64–72. doi: 10.1007/s004240000496. a). [DOI] [PubMed] [Google Scholar]
- Kim Y, Bang H. Kim D. TASK-3, a new member of the tandem pore K+ channel family. J Biol Chem. 2000;275:9340–9347. doi: 10.1074/jbc.275.13.9340. [DOI] [PubMed] [Google Scholar]
- Kim D, Cavanaugh EJ, Kim I. Carroll JL. Heteromeric TASK-1/TASK-3 is the major oxygen-sensitive background K+ channel in rat carotid body glomus cells. J Physiol. 2009;587:2963–2975. doi: 10.1113/jphysiol.2009.171181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kim D. Gnatenco C. TASK-5, a new member of the tandem-pore K+ channel family. Biochem Biophys Res Commun. 2001;284:923–930. doi: 10.1006/bbrc.2001.5064. [DOI] [PubMed] [Google Scholar]
- Kim Y, Gnatenco C, Bang H. Kim D. b Localization of TREK-2 K+ channel domains that regulate channel kinetics and sensitivity to pressure, fatty acids and pHi. Pflugers Arch. 2001;442:952–960. doi: 10.1007/s004240100626. [DOI] [PubMed] [Google Scholar]
- Kim E, Hwang EM, Yarishkin O, Yoo JC, Kim D, Park N, Cho M, Lee YS, Sun C-H, Yi G-S, Yoo J, Kang D, Han J, Hong S-G. Park J-Y. Enhancement of TREK1 channel surface expression by protein–protein interaction with β-COP. Biochem Biophys Res Commun. 2010;395:244–250. doi: 10.1016/j.bbrc.2010.03.171. [DOI] [PubMed] [Google Scholar]
- Kim D, Sladek CD, Aguado-Velasco C. Mathiasen JR. Arachidonic acid activation of a new family of K+ channels in cultured rat neuronal cells. J Physiol. 1995;484:643–660. doi: 10.1113/jphysiol.1995.sp020693. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Koh SD, Monaghan K, Sergeant GP, Ro S, Walker RL, Sanders KM. Horowitz B. TREK-1 regulation by nitric oxide and cGMP-dependent protein kinase. An essential role in smooth muscle inhibitory neurotransmission. J Biol Chem. 2001;276:44338–44346. doi: 10.1074/jbc.M108125200. [DOI] [PubMed] [Google Scholar]
- Kubo Y, Adelman JP, Clapham DE, Jan LY, Karschin A, Kurachi Y, Lazdunski M, Nichols CG, Seino S. Vandenberg CA. International Union of Pharmacology. LIV. Nomenclature and molecular relationships of inwardly rectifying potassium channels. Pharmacol Rev. 2005;57:509–526. doi: 10.1124/pr.57.4.11. [DOI] [PubMed] [Google Scholar]
- Lafrenière RG, Cader MZ, Poulin J-F, Andres-Enguix I, Simoneau M, Gupta N, Boisvert K, Lafrenière F, McLaughlan S, Dubé M-P, Marcinkiewicz MM, Ramagopalan S, Ansorge O, Brais B, Sequeiros J, Pereira-Monteiro JM, Griffiths LR, Tucker SJ, Ebers G. Rouleau GA. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med. 2010;16:1157–1160. doi: 10.1038/nm.2216. [DOI] [PubMed] [Google Scholar]
- Laigle C, Confort-Gouny S, Le, Fur Y, Cozzone PJ. Viola A. Deletion of TRAAK potassium channel affects brain metabolism and protects against ischemia. PLoS One. 2012;7:e53266. doi: 10.1371/journal.pone.0053266. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lauritzen I, Chemin J, Honoré E, Jodar M, Guy N, Lazdunski M. Jane Patel A. Cross-talk between the mechano-gated K2P channel TREK-1 and the actin cytoskeleton. EMBO Rep. 2005;6:642–648. doi: 10.1038/sj.embor.7400449. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lauritzen I, Zanzouri M, Honoré E, Duprat F, Ehrengruber MU, Lazdunski M. Patel AJ. K+-dependent cerebellar granule neuron apoptosis. Role of TASK leak K+ channels. J Biol Chem. 2003;278:32068–32076. doi: 10.1074/jbc.M302631200. [DOI] [PubMed] [Google Scholar]
- Lesage F. Barhanin J. Molecular Physiology of pH-sensitive background K2P channels. Physiology (Bethesda) 2011;26:424–437. doi: 10.1152/physiol.00029.2011. [DOI] [PubMed] [Google Scholar]
- Lesage F, Guillemare E, Fink M, Duprat F, Lazdunski M, Romey G. Barhanin J. a TWIK-1, a ubiquitous human weakly inward rectifying K+ channel with a novel structure. EMBO J. 1996;15:1004–1011. [PMC free article] [PubMed] [Google Scholar]
- Lesage F, Maingret F. Lazdunski M. a Cloning and expression of human TRAAK, a polyunsaturated fatty acids-activated and mechano-sensitive K+ channel. FEBS Lett. 2000;471:137–140. doi: 10.1016/s0014-5793(00)01388-0. [DOI] [PubMed] [Google Scholar]
- Lesage F, Reyes R, Fink M, Duprat F, Guillemare E. Lazdunski M. b Dimerization of TWIK-1 K+ channel subunits via a disulfide bridge. EMBO J. 1996;15:6400–6407. [PMC free article] [PubMed] [Google Scholar]
- Lesage F, Terrenoire C, Romey G. Lazdunski M. b Human TREK2, a 2P domain mechano-sensitive K+ channel with multiple regulations by polyunsaturated fatty acids, lysophospholipids, and Gs, Gi, and Gq protein-coupled receptors. J Biol Chem. 2000;275:28398–28405. doi: 10.1074/jbc.M002822200. [DOI] [PubMed] [Google Scholar]
- L’Hoste S, Barriere H, Belfodil R, Rubera I, Duranton C, Tauc M, Poujeol C, Barhanin J. Poujeol P. Extracellular pH alkalinization by Cl−/HCO3− exchanger is crucial for TASK2 activation by hypotonic shock in proximal cell lines from mouse kidney. Am J Physiol Renal Physiol. 2007;292:F628–F638. doi: 10.1152/ajprenal.00132.2006. [DOI] [PubMed] [Google Scholar]
- Li XT, Dyachenko V, Zuzarte M, Putzke C, Preisig-Müller R, Isenberg G. Daut J. The stretch-activated potassium channel TREK-1 in rat cardiac ventricular muscle. Cardiovasc Res. 2006;69:86–97. doi: 10.1016/j.cardiores.2005.08.018. [DOI] [PubMed] [Google Scholar]
- Liang B, Soka M, Christensen AH, Olesen MS, Larsen AP, Knop FK, Wang F, Nielsen JB, Andersen MN, Humphreys D, Mann SA, Huttner IG, Vandenberg JI, Svendsen JH, Haunsø S, Preiss T, Seebohm G, Olesen S-P, Schmitt N. Fatkin D. Genetic variation in the two-pore domain potassium channel, TASK-1, may contribute to an atrial substrate for arrhythmogenesis. J Mol Cell Cardiol. 2014;67:69–76. doi: 10.1016/j.yjmcc.2013.12.014. [DOI] [PubMed] [Google Scholar]
- Linden A-M, Aller MI, Leppä E, Vekovischeva O, Aitta-aho T, Veale EL, Mathie A, Rosenberg P, Wisden W. Korpi ER. The in vivo contributions of TASK-1-containing channels to the actions of inhalation anesthetics, the α2 adrenergic sedative dexmedetomidine, and cannabinoid agonists. J Pharmacol Exp Ther. 2006;317:615–626. doi: 10.1124/jpet.105.098525. [DOI] [PubMed] [Google Scholar]
- Linden A-M, Sandu C, Aller MI, Vekovischeva OY, Rosenberg PH, Wisden W. Korpi ER. TASK-3 knockout mice exhibit exaggerated nocturnal activity, impairments in cognitive functions, and reduced sensitivity to inhalation anesthetics. J Pharmacol Exp Ther. 2007;323:924–934. doi: 10.1124/jpet.107.129544. [DOI] [PubMed] [Google Scholar]
- Liu C, Au JD, Zou HL, Cotten JF. Yost CS. Potent activation of the human tandem pore domain K channel TRESK with clinical concentrations of volatile anesthetics. Anesth Analg. 2004;99:1715–1722. doi: 10.1213/01.ANE.0000136849.07384.44. , table of contents. [DOI] [PubMed] [Google Scholar]
- Lloyd EE, Crossland RF, Phillips SC, Marrelli SP, Reddy AK, Taffet GE, Hartley CJ. Bryan RM. Disruption of K2P6.1 produces vascular dysfunction and hypertension in mice. Hypertension. 2011;58:672–678. doi: 10.1161/HYPERTENSIONAHA.111.175349. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lopes CMB, Rohács T, Czirják G, Balla T, Enyedi P. Logothetis DE. PIP2 hydrolysis underlies agonist-induced inhibition and regulates voltage gating of two-pore domain K+ channels. J Physiol. 2005;564:117–129. doi: 10.1113/jphysiol.2004.081935. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lotshaw DP. Biophysical and pharmacological characteristics of native two-pore domain TASK channels in rat adrenal glomerulosa cells. J Membr Biol. 2006;210:51–70. doi: 10.1007/s00232-005-7012-x. [DOI] [PubMed] [Google Scholar]
- Ma L, Roman-Campos D, Austin ED, Eyries M, Sampson KS, Soubrier F, Germain M, Trégouët D-A, Borczuk A, Rosenzweig EB, Girerd B, Montani D, Humbert M, Loyd JE, Kass RS. Chung WK. A novel channelopathy in pulmonary arterial hypertension. N Engl J Med. 2013;369:351–361. doi: 10.1056/NEJMoa1211097. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ma L, Zhang X. Chen H. TWIK-1 two-pore domain potassium channels change ion selectivity and conduct inward leak sodium currents in hypokalemia. Sci Signal. 2011;4 doi: 10.1126/scisignal.2001726. , ra37. [DOI] [PubMed] [Google Scholar]
- Ma L, Zhang X, Zhou M. Chen H. Acid-sensitive TWIK and TASK two-pore domain potassium channels change ion selectivity and become permeable to sodium in extracellular acidification. J Biol Chem. 2012;287:37145–37153. doi: 10.1074/jbc.M112.398164. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maher BH, Taylor M, Stuart S, Okolicsanyi RK, Roy B, Sutherland HG, Haupt LM. Griffiths LR. Analysis of 3 common polymorphisms in the KCNK18 gene in an Australian migraine case-control cohort. Gene. 2013;528:343–346. doi: 10.1016/j.gene.2013.07.030. [DOI] [PubMed] [Google Scholar]
- Maingret F, Fosset M, Lesage F, Lazdunski M. Honoré E. TRAAK is a mammalian neuronal mechano-gated K+ channel. J Biol Chem. 1999a;274:1381–1387. doi: 10.1074/jbc.274.3.1381. [DOI] [PubMed] [Google Scholar]
- Maingret F, Lauritzen I, Patel AJ, Heurteaux C, Reyes R, Lesage F, Lazdunski M. Honoré E. a TREK-1 is a heat-activated background K+ channel. EMBO J. 2000;19:2483–2491. doi: 10.1093/emboj/19.11.2483. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maingret F, Patel AJ, Lesage F, Lazdunski M. Honoré E. b Mechano- or acid stimulation, two interactive modes of activation of the TREK-1 potassium channel. J Biol Chem. 1999;274:26691–26696. doi: 10.1074/jbc.274.38.26691. [DOI] [PubMed] [Google Scholar]
- Maingret F, Patel AJ, Lesage F, Lazdunski M. Honoré E. b Lysophospholipids open the two-pore domain mechano-gated K+ channels TREK-1 and TRAAK. J Biol Chem. 2000;275:10128–10133. doi: 10.1074/jbc.275.14.10128. [DOI] [PubMed] [Google Scholar]
- Mathie A, Al-Moubarak E. Veale EL. Gating of two pore domain potassium channels. J Physiol. 2010;588:3149–3156. doi: 10.1113/jphysiol.2010.192344. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mazella J, Pétrault O, Lucas G, Deval E, Béraud-Dufour S, Gandin C, El-Yacoubi M, Widmann C, Guyon A, Chevet E, Taouji S, Conductier G, Corinus A, Coppola T, Gobbi G, Nahon J-L, Heurteaux C. Borsotto M. Spadin, a sortilin-derived peptide, targeting rodent TREK-1 channels: a new concept in the antidepressant drug design. PLoS Biol. 2010;8:e1000355. doi: 10.1371/journal.pbio.1000355. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Meadows HJ. Randall AD. Functional characterisation of human TASK-3, an acid-sensitive two-pore domain potassium channel. Neuropharmacology. 2001;40:551–559. doi: 10.1016/s0028-3908(00)00189-1. [DOI] [PubMed] [Google Scholar]
- Millar ID, Taylor HC, Cooper GJ, Kibble JD, Barhanin J. Robson L. Adaptive downregulation of a quinidine-sensitive cation conductance in renal principal cells of TWIK-1 knockout mice. Pflugers Arch. 2006;453:107–116. doi: 10.1007/s00424-006-0107-0. [DOI] [PubMed] [Google Scholar]
- Miller AN. Long SB. Crystal structure of the human two-pore domain potassium channel K2P1. Science. 2012;335:432–436. doi: 10.1126/science.1213274. [DOI] [PubMed] [Google Scholar]
- Moha Ou Maati H, Veyssiere J, Labbal F, Coppola T, Gandin C, Widmann C, Mazella J, Heurteaux C. Borsotto M. Spadin as a new antidepressant: absence of TREK-1-related side effects. Neuropharmacology. 2012;62:278–288. doi: 10.1016/j.neuropharm.2011.07.019. [DOI] [PubMed] [Google Scholar]
- Morton MJ, O’Connell AD, Sivaprasadarao A. Hunter M. Determinants of pH sensing in the two-pore domain K+ channels TASK-1 and -2. Pflugers Arch. 2003;445:577–583. doi: 10.1007/s00424-002-0901-2. [DOI] [PubMed] [Google Scholar]
- Mu D, Chen L, Zhang X, See L-H, Koch CM, Yen C, Tong JJ, Spiegel L, Nguyen KCQ, Servoss A, Peng Y, Pei L, Marks JR, Lowe S, Hoey T, Jan LY, McCombie WR, Wigler MH. Powers S. Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene. Cancer Cell. 2003;3:297–302. doi: 10.1016/s1535-6108(03)00054-0. [DOI] [PubMed] [Google Scholar]
- Mulkey DK, Talley EM, Stornetta RL, Siegel AR, West GH, Chen X, Sen N, Mistry AM, Guyenet PG. Bayliss DA. TASK channels determine pH sensitivity in select respiratory neurons but do not contribute to central respiratory chemosensitivity. J Neurosci. 2007;27:14049–14058. doi: 10.1523/JNEUROSCI.4254-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murbartián J, Lei Q, Sando JJ. Bayliss DA. Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels. J Biol Chem. 2005;280:30175–30184. doi: 10.1074/jbc.M503862200. [DOI] [PubMed] [Google Scholar]
- Nie X, Arrighi I, Kaissling B, Pfaff I, Mann J, Barhanin J. Vallon V. Expression and insights on function of potassium channel TWIK-1 in mouse kidney. Pflugers Arch. 2005;451:479–488. doi: 10.1007/s00424-005-1480-9. [DOI] [PubMed] [Google Scholar]
- Niemeyer MI, Cid LP, Peña-Münzenmayer G. Sepúlveda FV. Separate gating mechanisms mediate the regulation of K2P potassium channel TASK-2 by intra- and extracellular pH. J Biol Chem. 2010;285:16467–16475. doi: 10.1074/jbc.M110.107060. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Niemeyer MI, González-Nilo FD, Zúñiga L, González W, Cid LP. Sepúlveda FV. Gating of two-pore domain K+ channels by extracellular pH. Biochem Soc Trans. 2006;34:899–902. doi: 10.1042/BST0340899. [DOI] [PubMed] [Google Scholar]
- Niemeyer MI, González-Nilo FD, Zúñiga L, González W, Cid LP. Sepúlveda FV. Neutralization of a single arginine residue gates open a two-pore domain, alkali-activated K+ channel. Proc Natl Acad Sci U S A. 2007;104:666–671. doi: 10.1073/pnas.0606173104. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noël J, Sandoz G. Lesage F. Molecular regulations governing TREK and TRAAK channel functions. Channels (Austin) 2011;5:402–409. doi: 10.4161/chan.5.5.16469. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Noël J, Zimmermann K, Busserolles J, Deval E, Alloui A, Diochot S, Guy N, Borsotto M, Reeh P, Eschalier A. Lazdunski M. The mechano-activated K+ channels TRAAK and TREK-1 control both warm and cold perception. EMBO J. 2009;28:1308–1318. doi: 10.1038/emboj.2009.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nogueira EF, Gerry D, Mantero F, Mariniello B. Rainey WE. The role of TASK1 in aldosterone production and its expression in normal adrenal and aldosterone-producing adenomas. Clin Endocrinol (Oxf) 2010;73:22–29. doi: 10.1111/j.1365-2265.2009.03738.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- O’Kelly I, Butler MH, Zilberberg N. Goldstein SAN Forward transport. 14-3-3 binding overcomes retention in endoplasmic reticulum by dibasic signals. Cell. 2002;111:577–588. doi: 10.1016/s0092-8674(02)01040-1. [DOI] [PubMed] [Google Scholar]
- Ozaita A. Vega-Saenz de Miera E. Cloning of two transcripts, HKT4.1a and HKT4.1b, from the human two-pore K+ channel gene KCNK4. Chromosomal localization, tissue distribution and functional expression. Brain Res Mol Brain Res. 2002;102:18–27. doi: 10.1016/s0169-328x(02)00157-2. [DOI] [PubMed] [Google Scholar]
- Pandit LM, Lloyd EE, Reynolds JO, Lawrence WS, Reynolds C, Wehrens XHT. Bryan RM. TWIK-2 channel deficiency leads to pulmonary hypertension through a rho-kinase-mediated process. Hypertension. 2014;64:1260–1265. doi: 10.1161/HYPERTENSIONAHA.114.03406. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel AJ, Honoré E, Lesage F, Fink M, Romey G. Lazdunski M. Inhalational anesthetics activate two-pore-domain background K+ channels. Nat Neurosci. 1999;2:422–426. doi: 10.1038/8084. [DOI] [PubMed] [Google Scholar]
- Patel AJ, Honoré E, Maingret F, Lesage F, Fink M, Duprat F. Lazdunski M. A mammalian two pore domain mechano-gated S-like K+ channel. EMBO J. 1998;17:4283–4290. doi: 10.1093/emboj/17.15.4283. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Patel AJ, Maingret F, Magnone V, Fosset M, Lazdunski M. Honoré E. TWIK-2, an inactivating 2P domain K+ channel. J Biol Chem. 2000;275:28722–28730. doi: 10.1074/jbc.M003755200. [DOI] [PubMed] [Google Scholar]
- Pei L, Wiser O, Slavin A, Mu D, Powers S, Jan LY. Hoey T. Oncogenic potential of TASK3 (Kcnk9) depends on K+ channel function. Proc Natl Acad Sci U S A. 2003;100:7803–7807. doi: 10.1073/pnas.1232448100. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Penton D, Bandulik S, Schweda F, Haubs S, Tauber P, Reichold M, Cong LD, El Wakil A, Budde T, Lesage F, Lalli E, Zennaro M-C, Warth R. Barhanin J. Task3 potassium channel gene invalidation causes low renin and salt-sensitive arterial hypertension. Endocrinology. 2012;153:4740–4748. doi: 10.1210/en.2012-1527. [DOI] [PubMed] [Google Scholar]
- Pereira V, Busserolles J, Christin M, Devilliers M, Poupon L, Legha W, Alloui A, Aissouni Y, Bourinet E, Lesage F, Eschalier A, Lazdunski M. Noël J. Role of the TREK2 potassium channel in cold and warm thermosensation and in pain perception. Pain. 2014;155:2534–2544. doi: 10.1016/j.pain.2014.09.013. [DOI] [PubMed] [Google Scholar]
- Piechotta PL, Rapedius M, Stansfeld PJ, Bollepalli MK, Erhlich G, Andres-Enguix I, Fritzenschaft H, Decher N, Sansom MSP, Tucker SJ. Baukrowitz T. The pore structure and gating mechanism of K2P channels. EMBO J. 2011;30:3607–3619. doi: 10.1038/emboj.2011.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Plant LD, Zuniga L, Araki D, Marks JD. Goldstein SAN. SUMOylation silences heterodimeric TASK potassium channels containing K2P1 subunits in cerebellar granule neurons. Sci Signal. 2012;5 doi: 10.1126/scisignal.2003431. , ra84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pountney DJ, Gulkarov I, Vega-Saenz de Miera E, Holmes D, Saganich M, Rudy B, Artman M. Coetzee WA. Identification and cloning of TWIK-originated similarity sequence (TOSS): a novel human 2-pore K+ channel principal subunit. FEBS Lett. 1999;450:191–196. doi: 10.1016/s0014-5793(99)00495-0. [DOI] [PubMed] [Google Scholar]
- Premkumar LS, Gage PW. Chung S-H. Coupled potassium channels induced by arachidonic acid in cultured neurons. Proc R Soc Lond B Biol Sci. 1990;242:17–22. doi: 10.1098/rspb.1990.0097. [DOI] [PubMed] [Google Scholar]
- Rahm A-K, Gierten J, Kisselbach J, Staudacher I, Staudacher K, Schweizer PA, Becker R, Katus HA. Thomas D. PKC-dependent activation of human K2P 18.1 K+ channels. Br J Pharmacol. 2012;166:764–773. doi: 10.1111/j.1476-5381.2011.01813.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rajan S, Plant LD, Rabin ML, Butler MH. Goldstein SAN. Sumoylation silences the plasma membrane leak K+ channel K2P1. Cell. 2005;121:37–47. doi: 10.1016/j.cell.2005.01.019. [DOI] [PubMed] [Google Scholar]
- Rajan S, Wischmeyer E, Karschin C, Preisig-Müller R, Grzeschik KH, Daut J, Karschin A. Derst C. THIK-1 and THIK-2, a novel subfamily of tandem pore domain K+ channels. J Biol Chem. 2001;276:7302–7311. doi: 10.1074/jbc.M008985200. [DOI] [PubMed] [Google Scholar]
- Rajan S, Wischmeyer E, Xin Liu G, Preisig-Müller R, Daut J, Karschin A. Derst C. TASK-3, a novel tandem pore domain acid-sensitive K+ channel. An extracellular histiding as pH sensor. J Biol Chem. 2000;275:16650–16657. doi: 10.1074/jbc.M000030200. [DOI] [PubMed] [Google Scholar]
- Renigunta V, Fischer T, Zuzarte M, Kling S, Zou X, Siebert K, Limberg MM, Rinné S, Decher N, Schlichthörl G. Daut J. a Cooperative endocytosis of the endosomal SNARE protein syntaxin-8 and the potassium channel TASK-1. Mol Biol Cell. 2014;25:1877–1891. doi: 10.1091/mbc.E13-10-0592. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Renigunta V, Yuan H, Zuzarte M, Rinné S, Koch A, Wischmeyer E, Schlichthörl G, Gao Y, Karschin A, Jacob R, Schwappach B, Daut J. Preisig-Müller R. The retention factor p11 confers an endoplasmic reticulum-localization signal to the potassium channel TASK-1. Traffic. 2006;7:168–181. doi: 10.1111/j.1600-0854.2005.00375.x. [DOI] [PubMed] [Google Scholar]
- Renigunta V, Zou X, Kling S, Schlichthörl G. Daut J. b Breaking the silence: functional expression of the two-pore-domain potassium channel THIK-2. Pflugers Arch. 2014;466:1735–1745. doi: 10.1007/s00424-013-1404-z. [DOI] [PubMed] [Google Scholar]
- Reyes R, Duprat F, Lesage F, Fink M, Salinas M, Farman N. Lazdunski M. Cloning and expression of a novel pH-sensitive two pore domain K+ channel from human kidney. J Biol Chem. 1998;273:30863–30869. doi: 10.1074/jbc.273.47.30863. [DOI] [PubMed] [Google Scholar]
- Rinné S, Renigunta V, Schlichthörl G, Zuzarte M, Bittner S, Meuth SG, Decher N, Daut J. Preisig-Müller R. A splice variant of the two-pore domain potassium channel TREK-1 with only one pore domain reduces the surface expression of full-length TREK-1 channels. Pflugers Arch. 2014;466:1559–1570. doi: 10.1007/s00424-013-1384-z. [DOI] [PubMed] [Google Scholar]
- Rodrigues N, Bennis K, Vivier D, Pereira V, Chatelain FC, Chapuy E, Deokar H, Busserolles J, Lesage F, Eschalier A. Ducki S. Synthesis and structure–activity relationship study of substituted caffeate esters as antinociceptive agents modulating the TREK-1 channel. Eur J Med Chem. 2014;75:391–402. doi: 10.1016/j.ejmech.2014.01.049. [DOI] [PubMed] [Google Scholar]
- Sabbadini M. Yost CS. Molecular biology of background K channels: insights from K2P knockout mice. J Mol Biol. 2009;385:1331–1344. doi: 10.1016/j.jmb.2008.11.048. [DOI] [PubMed] [Google Scholar]
- Sackin H. Mechanosensitive channels. Annu Rev Physiol. 1995;57:333–353. doi: 10.1146/annurev.ph.57.030195.002001. [DOI] [PubMed] [Google Scholar]
- Salinas M, Reyes R, Lesage F, Fosset M, Heurteaux C, Romey G. Lazdunski M. Cloning of a new mouse two-P domain channel subunit and a human homologue with a unique pore structure. J Biol Chem. 1999;274:11751–11760. doi: 10.1074/jbc.274.17.11751. [DOI] [PubMed] [Google Scholar]
- Sandoz G, Douguet D, Chatelain F, Lazdunski M. Lesage F. Extracellular acidification exerts opposite actions on TREK1 and TREK2 potassium channels via a single conserved histidine residue. Proc Natl Acad Sci U S A. 2009;106:14628–14633. doi: 10.1073/pnas.0906267106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandoz G, Tardy MP, Thümmler S, Feliciangeli S, Lazdunski M. Lesage F. Mtap2 is a constituent of the protein network that regulates twik-related K+ channel expression and trafficking. J Neurosci. 2008;28:8545–8552. doi: 10.1523/JNEUROSCI.1962-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandoz G, Thümmler S, Duprat F, Feliciangeli S, Vinh J, Escoubas P, Guy N, Lazdunski M. Lesage F. AKAP150, a switch to convert mechano-, pH- and arachidonic acid-sensitive TREK K+ channels into open leak channels. EMBO J. 2006;25:5864–5872. doi: 10.1038/sj.emboj.7601437. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sano Y, Inamura K, Miyake A, Mochizuki S, Kitada C, Yokoi H, Nozawa K, Okada H, Matsushime H. Furuichi K. A novel two-pore domain K+ channel, TRESK, is localized in the spinal cord. J Biol Chem. 2003;278:27406–27412. doi: 10.1074/jbc.M206810200. [DOI] [PubMed] [Google Scholar]
- Simkin D, Cavanaugh EJ. Kim D. Control of the single channel conductance of K2P10.1 (TREK-2) by the amino-terminus: role of alternative translation initiation. J Physiol. 2008;586:5651–5663. doi: 10.1113/jphysiol.2008.161927. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Talley EM. Bayliss DA. Modulation of TASK-1 (Kcnk3) and TASK-3 (Kcnk9) potassium channels: volatile anesthetics and neurotransmitters share a molecular site of action. J Biol Chem. 2002;277:17733–17742. doi: 10.1074/jbc.M200502200. [DOI] [PubMed] [Google Scholar]
- Thomas D, Plant LD, Wilkens CM, McCrossan ZA. Goldstein SAN. Alternative translation initiation in rat brain yields K2P2.1 potassium channels permeable to sodium. Neuron. 2008;58:859–870. doi: 10.1016/j.neuron.2008.04.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tulleuda A, Cokic B, Callejo G, Saiani B, Serra J. Gasull X. TRESK channel contribution to nociceptive sensory neurons excitability: modulation by nerve injury. Mol Pain. 2011;7:30. doi: 10.1186/1744-8069-7-30. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Veale EL, Hassan M, Walsh Y, Al-Moubarak E. Mathie A. Recovery of current through mutated TASK3 potassium channels underlying Birk Barel syndrome. Mol Pharmacol. 2014;85:397–407. doi: 10.1124/mol.113.090530. [DOI] [PubMed] [Google Scholar]
- Veale EL, Rees KA, Mathie A. Trapp S. Dominant negative effects of a non-conducting TREK1 splice variant expressed in brain. J Biol Chem. 2010;285:29295–29304. doi: 10.1074/jbc.M110.108423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Voloshyna I, Besana A, Castillo M, Matos T, Weinstein IB, Mansukhani M, Robinson RB, Cordon-Cardo C. Feinmark SJ. TREK-1 is a novel molecular target in prostate cancer. Cancer Res. 2008;68:1197–1203. doi: 10.1158/0008-5472.CAN-07-5163. [DOI] [PubMed] [Google Scholar]
- Wang W, Putra A, Schools GP, Ma B, Chen H, Kaczmarek LK, Barhanin J, Lesage F. Zhou M. The contribution of TWIK-1 channels to astrocyte K+ current is limited by retention in intracellular compartments. Front Cell Neurosci. 2013;7:246. doi: 10.3389/fncel.2013.00246. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Warth R, Barrière H, Meneton P, Bloch M, Thomas J, Tauc M, Heitzmann D, Romeo E, Verrey F, Mengual R, Guy N, Bendahhou S, Lesage F, Poujeol P. Barhanin J. Proximal renal tubular acidosis in TASK2 K+channel-deficient mice reveals a mechanism for stabilizing bicarbonate transport. Proc Natl Acad Sci U S A. 2004;101:8215–8220. doi: 10.1073/pnas.0400081101. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wei AD, Gutman GA, Aldrich R, Chandy KG, Grissmer S. Wulff H. International Union of Pharmacology. LII. Nomenclature and molecular relationships of calcium-activated potassium channels. Pharmacol Rev. 2005;57:463–472. doi: 10.1124/pr.57.4.9. [DOI] [PubMed] [Google Scholar]
- Williams S, Bateman A. O’Kelly I. Altered expression of two-pore domain potassium (K2P) channels in cancer. PLoS ONE. 2013;8:e74589. doi: 10.1371/journal.pone.0074589. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Yost CS, Oh I, Eger EI. Sonner JM. Knockout of the gene encoding the K2P channel KCNK7 does not alter volatile anesthetic sensitivity. Behav Brain Res. 2008;193:192–196. doi: 10.1016/j.bbr.2008.05.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zuzarte M, Heusser K, Renigunta V, Schlichthörl G, Rinné S, Wischmeyer E, Daut J, Schwappach B. Preisig-Müller R. Intracellular traffic of the K+ channels TASK-1 and TASK-3: role of N- and C-terminal sorting signals and interaction with 14-3-3 proteins. J Physiol. 2009;587:929–952. doi: 10.1113/jphysiol.2008.164756. [DOI] [PMC free article] [PubMed] [Google Scholar]


